Peptide And Anticoagulant Drugs Market Size, Share & Trends Analysis Report by Peptide Drug Type (Antibiotic, Hormonal, Antifungal, ACE Inhibitor), Anticoagulant Drug Type (Heparin, Edoxaban, Apixaban, Dabigatran, Rivaroxaban), Administration Route (Oral, Injectable), By Peptide Application (Neurological Disorders, Metabolic Disorders, Gastrointestinal Disorders, Diabetes, Cancer, Cardiovascular Disorder, Infectious Diseases), Region And Segment Forecasts, 2024-2031
Report ID :
1837 | Published :
2024-08-14 | Pages:
180 | Format:
PDF/EXCEL
The Global Peptide And Anticoagulant Drugs Market Size is valued at 904.77 million in 2023 and is predicted to reach 1,413.01 million by the year 2031 at a 5.81% CAGR during the forecast period for 2024-2031. ... Read More >>